4058 Journal of Medicinal Chemistry, 2008, Vol. 51, No. 13
Brief Articles
evaluation studies on novel 1,3-diarylpropenones. Bioorg. Med. Chem.
2001, 9, 337–345.
(2) Kim, D. Y.; Kim, K. H.; Kim, N. D.; Lee, K. Y.; Han, C. K.; Yoon,
J. H.; Moon, S. K.; Lee, S. S.; Seong, B. L. Design and biological
evaluation of novel tubulin inhibitors as antimitotic agents using a
pharmacophore binding model with tubulin. J. Med. Chem. 2006, 49,
5664–5670.
(3) Ono, M.; Hori, M.; Haratake, M.; Tomiyama, T.; Mori, H.; Nakayama,
M. Structure-activity relationship of chalcones and related derivatives
as ligands for detecting of ꢀ-amyloid plaques in the brain. Bioorg.
Med. Chem. 2007, 15, 6388–6396.
(4) Konieczny, M. T.; Konieczny, W.; Sabisz, M.; Skladanowski, A.;
Wakiec, R.; Augustynowicz-Kopec, E.; Zwolska, Z. Synthesis of
isomeric, oxathiolone fused chalcones, and comparison of their activity
toward various microorganisms and human cancer cells line. Chem.
Pharm. Bull. 2007, 55, 817–820.
(E)-3-(2-Hydroxy-3-methoxyphenyl)-1-(3,4,5-trifluorophenyl)-2-
propen-1-one (18). The title compound was obtained in 77% yield
from o-vanillin 6 and 3,4,5-trifluoroacetophenone (7c). Rf ) 0.3
(30% ethyl acetate/hexanes, v/v); IR (neat, NaCl) 3405, 2987, 1675,
1540, 1455, 1247, 1130, 1060 cm-1; 1H NMR (500 MHz, CDCl3)
δ 7.99 (d, J ) 15.5 Hz, 1H, vinyl), 7.76 (d, J ) 7.5 Hz, 2H, Ar-H),
7.34 (d, J ) 15.5, Hz, 1H, vinyl), 7.23 (dd, J ) 3.5, 3.5 Hz, 1H,
Ar-H), 7.18 (d, J ) 6.5 Hz, 1H, Ar-H), 6.93 (d, J ) 7.5 Hz, 1H,
Ar-H), 5.54 (s, 1H, OH), 3.91 (s, 3H, OMe); HRMS calculated
for C16H12F3O3: 309.0739 [M + H]+. Found: 309.0722. Anal.
(C16H14F3O3) C, H, O.
(E)-1-(3-Fluoro-4-methoxyphenyl)-3-(2-hydroxy-3-methoxyphe-
nyl)-2-propen-1-one (19). The title compound was obtained in 81%
yield from o-vanillin 6 and 3-fluoro-4-methoxyacetophenone (7d).
Rf ) 0.3 (25% ethyl acetate/hexanes, v/v); IR (neat, NaCl) 3352,
(5) Gschwendt, M.; Kittstein, W.; Furstenberger, G.; Marks, F. The mouse
ear edema: a quantitatively evaluable assay for tumor promoting
compounds and for inhibitors of tumor promotion. Cancer Lett. 1984,
25, 177–185.
1
2979, 1687, 1466, 1285, 1122, 1084 cm-1; H NMR (500 MHz,
CDCl3) δ 8.20 (d, J ) 15.5 Hz, 1H, vinyl), 8.11-8.06 (m, 2H,
Ar-H), 7.96 (d, J ) 15.5 Hz, 1H, vinyl), 7.41 (dd, J ) 3.5, 3.5
Hz, 1H, Ar-H), 7.22 (t, J ) 8.4 Hz, 1H, Ar-H), 7.16-7.03 (m,
2H, Ar-H), 6.56 (s, 1H, OH), 4.21 (s, 3H, OMe), 4.17 (s, 3H,
OMe); HRMS calculated for C17H16FO4: 303.1033 [M + H]+.
Found: 303.1053. Anal. (C17H15FO4) C, H, O.
(6) Nowakowska, Z. A review of anti-infective and anti-inflammatory
chalcones. Eur. J. Med. Chem. 2007, 42, 125–137.
(7) Opletalova, V.; Jahodar, L.; Jun, D.; Opletal, L. Chalcones (1,3-
diarylpropen-1-ones) and their analogs as potential therapeutic agents
for diseases of the cardiovascular system. Ceska SloV. Farm. 2003,
52, 12–19.
(8) Afanas’ev, I. B. Signaling functions of free radicals superoxide & nitric
oxide under physiological & pathological conditions. Mol. Biotechnol.
2007, 37, 2–4.
(9) Esposito, E.; Capasso, M.; di Tomasso, N.; Corona, C.; Pellegrini,
F.; Uncini, A.; Vitaglione, P.; Fogliano, V.; Piantelli, M.; Sensi,
S. L. Antioxidant strategies based on tomato-enriched food or
pyruvate do not affect disease onset and survival in an animal model
of amyotrophic lateral sclerosis. Brain Res. 2007, 1168, 90–96.
(10) Foresti, R.; Hoque, M.; Monti, D.; Green, C. J.; Motterlini, R. Differential
activation of heme oxygenase-1 by chalcones and rosolic acid in
endothelial cells. J. Pharmacol. Exp. Ther. 2005, 312, 686–693.
(11) Kume, T.; Kawai, Y.; Yoshida, K.; Nakamizo, T.; Kanki, R.;
Sawada, H.; Katsuki, H.; Shimohama, S.; Sugimoto, H.; Akaike,
A. Protective effect of serofendic acid on glutamate-induced
neurotoxicity in rat cultured motor neurons. Neurosci. Lett. 2005,
383, 199–202.
(12) Oh, S.; Jang, S.; Kim, D.; Han, I. O.; Jung, J. C. Synthesis and
evaluation of biological properties of benzylideneacetophenone deriva-
tives. Arch. Pharm. Res. 2006, 29, 469–475.
(13) Arty, I. S.; Timmerman, H.; Samhoedi, M.; Sastrohamidjojo, S.;
Van der Goot, H. Synthesis of benzylideneacetophenones and their
inhibition of lipid peroxidation. Eur. J. Med. Chem. 2000, 35, 449–
457.
(14) Lawrence, N. J.; Patterson, R. P.; Ooi, L. L.; Cook, D.; Ducki, S.
Effects of R-substitutions on structure and biological activity of
anticancer chalcones. Bioorg. Med. Chem. Lett. 2006, 16, 5844
5848.
(15) Maiti, A.; Cuendet, M.; Croy, V. L.; Endringer, D. C.; Pezzuto, J. M.;
Cushman, M. Synthesis and biological evaluation of (()-abyssinone
II and its analogues as aromatase inhibitors for chemoprevention of
breast cancer. J. Med. Chem. 2007, 50, 2799–2806.
(16) Bhat, B. A.; Dhar, K. L.; Puri, S. C.; Saxena, A. K.; Shanmugavel,
M.; Qazi, G. N. Synthesis and biological evaluation of chalcones and
their derived pyrazoles as potential cytotoxic agents. Bioorg. Med.
Chem. Lett. 2005, 15, 3177–3180.
(17) Lawinski, M.; Sledzinski, Z.; Kubasik-Juraniec, J.; Spodnik, J. H.;
Wozniak, M.; Boguslawski, W. Does resveratrol prevent free radical-
induced acute pancreatitis? Pancreas 2005, 31, 43–47.
(18) Sivakumar, P. M.; Geetha Babu, S. K.; Mukesh, D. QSAR studies
on chalcones and flavonoids as anti-tuberculosis agents using
genetic function approximation (GFA) method. Chem. Pharm. Bull.
2007, 55, 44–49.
Measurement of Cell Viability. Cortical neuronal cell number
and viability were assessed by using the reagent WST-1 (Roche,
Indianapolis, IN). This colorimetric assay measures the metabolic
activity of viable cells based on cleavage of the tetrazolium salt
WST-1 substrate 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-
tetrazolio-1,3-benzene disulfonate] into formazan by mitochon-
dria dehydrogenase in live cells. This was followed by incubation
with WST-1 reagent at a dilution of 1:10 in the original
conditioned media at 37 °C for 2 h. After thorough shaking, the
formazan produced by the metabolically active cells in each
sample was measured at a wavelength of 450 nm and a reference
wavelength of 650 nm. Absorbance readings were normalized
against control wells with untreated cells. Neuronal death was
analyzed 24 h later, and the percentage of neurons undergo-
ing actual neuronal death was normalized to the mean value
found after a 24 h exposure to 300 µM NMDA (defined as 0) or
a sham control (defined as 100).
Molecular Modeling. The lower energy conformers for 8-20
were searched by a molecular mechanics force field (MMFF)
analysis19 and were submitted to a geometry optimization and
energy calculations by density functional theories (DFT) model20
calculation at the B3LYP 6-31G** level. The HOMO, LUMO,
and dipole values of the selected conformers were also calcu-
lated. All calculations and graphical representations were
performed by using the SPARTAN 06 for Windows software
package.
Acknowledgment. This work was supported by a KOSEF
Brain Neurobiology grant (2007), Ewha Global Challenge
(BK21) grant, and Korean Research Foundation Grant funded
by the Korean Government (MOEHRD) (Grant KRF-2006-
312-C00267), the Republic of Korea. Y.L., D.M., H.J., and
M.O. appreciate the fellowship from the BK21 program from
the Ministry of Education and Human Resources Develop-
ment. Y.L. thanks the Seoul Science Fellowship Program and
Grant 20070301-034-026-007-04-00 from BioGreen 21 Pro-
gram, Rural Development Administration, Korea.
(19) Halgren, T. A. Merck molecular force field. I. Basis, form, scope,
parameterization, and performance of MMFF94. J. Comput. Chem.
1996, 17, 490–519.
Supporting Information Available: Spectral data of 8, 12, 16,
17, and 20, experimental procedures for synthesis, frontier orbital
maps of 8-20, and biological evaluations (radical scavenging test,
cell cultures, and DPPH bleaching kinetics). This material is
(20) Kohn, W.; Becks, A. D.; Parr, R. G. Density functional theory of
electronic structure. J. Phys. Chem. 1996, 100, 12974–12980.
References
(1) Mukherjee, S.; Kumar, V.; Prasad, A. K.; Raj, H. G.; Bracke, M. E.;
Olsen, C. E.; Jain, S. C.; Parmar, V. S. Synthetic and biological activity
JM800221G